N. Del-papa and E. Zaccara, From mechanisms of action to therapeutic application: A review on current therapeutic approaches and future directions in systemic sclerosis, Best Pract. Res. Clin. Rheumatol, vol.29, pp.756-769, 2015.

J. Fransen, D. Popa-diaconu, R. Hesselstrand, P. Carreira, G. Valentini et al., Clinical prediction of 5-year survival in systemic sclerosis: Validation of a simple prognostic model in EUSTAR centres, Ann. Rheum. Dis, vol.70, pp.1788-1792, 2011.

K. M. Sullivan, E. A. Goldmuntz, L. Keyes-elstein, P. A. Mcsweeney, A. Pinckney et al., Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma, N. Engl. J. Med, vol.378, pp.35-47, 2018.

J. M. Van-laar, D. Farge, J. K. Sont, K. Naraghi, Z. Marjanovic et al., Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: A randomized clinical trial, JAMA, vol.311, pp.2490-2498, 2014.

R. K. Burt and D. Farge, Systemic sclerosis: Autologous HSCT is efficacious, but can we make it safer?, Nat. Rev. Rheumatol, vol.14, pp.189-191, 2018.

L. Da-silva-meirelles, Mesenchymal stem cells reside in virtually all post-natal organs and tissues, J. Cell Sci, vol.119, pp.2204-2213, 2006.

P. Rozier, A. Maria, R. Goulabchand, C. Jorgensen, P. Guilpain et al., Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?, Front. Immunol, vol.9, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02304369

Y. Wu, S. Huang, J. Enhe, K. Ma, S. Yang et al., Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice, Int. Wound J, vol.11, pp.701-710, 2014.

A. Bronckaers, P. Hilkens, W. Martens, P. Gervois, J. Ratajczak et al., Lambrichts, I. Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis, Pharmacol. Ther, vol.143, pp.181-196, 2014.

X. Liang, Y. Ding, Y. Zhang, H. Tse, and Q. Lian, Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives, Cell Transplant, vol.23, pp.1045-1059, 2014.

S. H. Lee, E. J. Lee, S. Y. Lee, J. H. Kim, J. J. Shim et al., The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice, Exp. Lung Res, vol.40, pp.117-125, 2014.

M. Uji, Y. Kureya, K. Yamada, T. Watanabe, K. Konishi et al., Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model, Mech. Lung Inj. Repair, vol.46, pp.81-91, 2015.

J. Tashiro, S. J. Elliot, D. J. Gerth, X. Xia, S. Pereira-simon et al., Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis, Transl. Res, vol.166, pp.554-567, 2015.

A. T. Maria, K. Toupet, C. Bony, N. Pirot, M. C. Vozenin et al., Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis: MESENCHYMAL STEM CELLS IN MURINE SSc. Arthritis Rheumatol, vol.68, pp.1013-1025, 2016.

N. Scuderi, S. Ceccarelli, M. G. Onesti, P. Fioramonti, C. Guidi et al., Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis, Cell Transplant, vol.22, pp.779-795, 2013.

M. G. Onesti, P. Fioramonti, S. Carella, P. Fino, C. Marchese et al., Improvement of Mouth Functional Disability in Systemic Sclerosis Patients over One Year in a Trial of Fat Transplantation versus Adipose-Derived Stromal Cells, Stem Cells Int, 2016.

B. Granel, A. Daumas, E. Jouve, J. R. Harlé, P. S. Nguyen et al., Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: An open-label phase I trial, Ann. Rheum. Dis, vol.74, pp.2175-2182, 2015.

A. Daumas, J. Magalon, E. Jouve, R. Truillet, D. Casanova et al., Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients, Curr. Res. Transl. Med, vol.65, pp.40-43, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01797455

D. Benedetto, P. Cipriani, P. Ruscitti, P. Liakouli, V. Giacomelli et al., Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al, Ann. Rheum. Dis, 2019.

J. Magalon, M. Velier, S. Simoncini, F. Dignat-george, B. Granel et al., Response to: «Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al, Ann. Rheum. Dis, 2019.

M. Manetti, Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis?, Ann. Rheum. Dis, 2019.

M. Velier, J. Magalon, S. Simoncini, F. Dignat-george, B. Granel et al., Response to: « Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis? » by Manetti, Ann. Rheum. Dis, 2019.

D. Benedetto, P. Panzera, N. Cipriani, P. Mastroiaco, V. Tessitore et al., Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling, Sci. Rep, vol.9, p.7144, 2019.

R. Lee, N. Del-papa, M. Introna, C. F. Reese, M. Zemskova et al., Adipose-derived mesenchymal stromal/stem cells in systemic sclerosis: Alterations in function and beneficial effect on lung fibrosis are regulated by caveolin-1, J. Scleroderma Relat. Disord, vol.4, pp.127-136, 2019.

F. Virzì, P. Bianca, A. Giammona, T. Apuzzo, S. Di-franco et al., Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients, Stem Cell Res. Ther, vol.8, p.236, 2017.

B. Delorme and P. Charbord, Culture and characterization of human bone marrow mesenchymal stem cells, Methods Mol. Med, vol.140, pp.67-81, 2007.

S. Viau, L. Chabrand, S. Eap, J. Lorant, K. Rouger et al., Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells, PLoS ONE, vol.12, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01524322

T. Korff, S. Kimmina, G. Martiny-baron, and H. G. Augustin, Blood vessel maturation in a 3-dimensional spheroidal coculture model: Direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness, FASEB J, vol.15, pp.447-457, 2001.

J. Eglinger, H. Karsjens, and E. Lammert, Quantitative assessment of angiogenesis and pericyte coverage in human cell-derived vascular sprouts, vol.37, 2017.

B. Delorme, J. Ringe, N. Gallay, Y. Le-vern, D. Kerboeuf et al., Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells, Blood, vol.111, pp.2631-2635, 2008.

M. L. Dominici, K. Le-blanc, I. Mueller, I. Slaper-cortenbach, F. C. Marini et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, pp.315-317, 2006.

J. Larghero, D. Farge, A. Braccini, S. Lecourt, A. Scherberich et al., Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis, Ann. Rheum. Dis, vol.67, pp.443-449, 2008.

M. Griffin, C. M. Ryan, O. Pathan, D. Abraham, C. P. Denton et al., Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: Implications for regenerative medicine, Stem Cell Res. Ther, vol.8, p.23, 2017.

C. Capelli, E. Zaccara, P. Cipriani, P. Di-benedetto, W. Maglione et al., Phenotypical and Functional Characteristics of In Vitro-Expanded Adipose-Derived Mesenchymal Stromal Cells From Patients With Systematic Sclerosis, Cell Transplant, vol.26, pp.841-854, 2017.

V. Turinetto, E. Vitale, and C. Giachino, Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy, IJMS, vol.17, 1164.

P. Cipriani, P. Di-benedetto, V. Liakouli, B. Del-papa, M. Di-padova et al., Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (T reg s ) with a functional phenotype: Implications for cellular-based therapy: SSc-MSC preserve immunomodulatory abilities, Clin. Exp. Immunol, vol.173, pp.195-206, 2013.

A. E. Wyman and S. P. Atamas, Sirtuins and Accelerated Aging in Scleroderma, Curr. Rheumatol. Rep, vol.20, 2018.

M. Najar, F. Bouhtit, R. Melki, H. Afif, A. Hamal et al., Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges, J. Clin. Med, vol.8, p.626, 2019.

J. Magalon, M. Velier, S. Simoncini, P. François, B. Bertrand et al., Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis, Ann. Rheum. Dis, vol.78, pp.391-398, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02555747

P. Cipriani, P. Di-benedetto, P. Ruscitti, V. Liakouli, O. Berardicurti et al., Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis, J. Rheumatol, vol.43, pp.1340-1349, 2016.

P. A. Nicolosi, E. Tombetti, N. Maugeri, P. Rovere-querini, S. Brunelli et al., Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis, Stem Cells Int, p.4636859, 2016.

A. Almadori, M. Griffin, C. M. Ryan, D. F. Hunt, E. Hansen et al., Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis, PLoS ONE, vol.14, 2019.

M. Manetti, E. Romano, I. Rosa, B. S. Fioretto, E. Praino et al., Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications, J. Clin. Med, 1256.

T. Nenasheva, A. Nikolaev, D. Diykanov, A. Sukhanova, E. Tcyganov et al., The introduction of mesenchymal stromal cells induces different immunological responses in the lungs of healthy and M. tuberculosis infected mice. Olszewski MA, éditeur, PLoS ONE, vol.12, 2017.